Transcatheter mitral valve replacement to treat rheumatic mitral stenosis: a case series
2024

Transcatheter Mitral Valve Replacement for Rheumatic Mitral Stenosis

Sample size: 5 publication 10 minutes Evidence: moderate

Author Information

Author(s): Jin Ping, Guo Hong, Mao Yu, Zhai Mengen, Liu Yang, Yang Jian

Primary Institution: Xijing Hospital, Air Force Medical University, Xi’an, China

Hypothesis

We sought to evaluate the early experience of patients with RMS undergoing transcatheter mitral valve replacement (TMVR).

Conclusion

Our early experience with TMVR in RMS patients suggests that it is a safe and feasible procedure.

Supporting Evidence

  • TMVR was successful in all patients.
  • 60% of patients had no paravalvular leakage postoperatively.
  • No deaths occurred at the 30-day follow-up.
  • All patients had an improvement of ≥1 on the New York Heart Association functional rating.

Takeaway

Doctors used a new method to help patients with a heart valve problem, and it worked well for everyone.

Methodology

This was a retrospective study involving 5 RMS patients who underwent TMVR, with evaluations before and after the procedure.

Potential Biases

There may be a lack of standardized procedures for device selection and deployment.

Limitations

The study is limited by its small sample size and being a single-center study.

Participant Demographics

The median age of patients was 61 years, with 60% male.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3389/fcvm.2024.1424105

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication